Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. | Zendy

Hiltrud S. Mueller | Zendy; Lawrence S. Cohen | Zendy; Eugene Braunwald | Zendy; Sandra Forman | Zendy; Frederick Feit | Zendy; Allan M. Ross | Zendy; Marc J. Schweiger | Zendy; Henry S. Cabin | Zendy; Richard Davison | Zendy; David P. Miller | Zendy

Open Access

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

Author(s) -

Hiltrud S. Mueller,

Lawrence S. Cohen,

Eugene Braunwald,

Sandra Forman,

Frederick Feit,

Allan M. Ross,

Marc J. Schweiger,

Henry S. Cabin,

Richard Davison,

David P. Miller

Publication year - 1992

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.85.4.1254

Subject(s) - medicine , thrombolysis , myocardial infarction , cardiogenic shock , timi , cardiology , angina , mortality rate , diabetes mellitus , endocrinology

Thrombolysis has altered treatment of acute myocardial infarction (AMI). Therefore, reevaluation of predictors of outcome and treatment strategies is appropriate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog